Bio Vitos Pharma AB (publ) operates as a medical technology company in Sweden and internationally. The company develops and commercializes Helge, which detects hemolysis in vacuum tubes and blood gas samples. It serves emergency departments in the European Union and the United States. It has a collaboration agreement with KFUM Kalmar to conduct a research study. The company was formerly known as Hemcheck Sweden AB (publ) and changed its name to Bio Vitos Pharma AB (publ) in December 2023. Bio Vitos Pharma AB (publ) was incorporated in 2010 and is based in Solna, Sweden.
Metrics to compare | BIOVIT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOVITPeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −6.0x | −0.5x | |
PEG Ratio | 0.00 | −0.07 | 0.00 | |
Price/Book | 0.0x | 1.5x | 2.6x | |
Price / LTM Sales | 0.0x | 4.6x | 3.2x | |
Upside (Analyst Target) | 0.0% | 0.0% | 41.2% | |
Fair Value Upside | Unlock | −4.8% | 6.2% | Unlock |